Hepatitis B Virus Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hepatitis B Virus stocks.

Hepatitis B Virus Stocks Recent News

Date Stock Title
May 22 BMY Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
May 22 BMY Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries
May 22 VIR Multiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024
May 22 BMY Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines
May 22 BMY NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
May 22 ABUS Arbutus to Present Imdusiran Data at EASL Congress 2024
May 22 BMY Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
May 21 BMY Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
May 21 VIR Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024
May 21 BMY 1 Stock I Wouldn't Touch With a 10-Foot Pole
May 21 BMY Bristol-Myers says FDA has revised decision date on injected Opdivo
May 21 BMY Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
May 20 INO Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)
May 20 NNVC Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
May 18 BMY Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
May 17 IONS Ionis, Biogen Down on Ending Development of ALS Drug
May 17 BMY AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
May 17 ABUS Update: Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
May 17 ABUS Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program
May 17 IONS Ionis (IONS), Biogen Down on Ending Development of ALS Drug
Hepatitis B Virus

Hepatitis B virus (HBV), is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

Browse All Tags